113 related articles for article (PubMed ID: 29227545)
1. Overexpression of Sirt6 is a novel biomarker of malignant human colon carcinoma.
Geng CH; Zhang CL; Zhang JY; Gao P; He M; Li YL
J Cell Biochem; 2018 May; 119(5):3957-3967. PubMed ID: 29227545
[TBL] [Abstract][Full Text] [Related]
2. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.
Choe M; Brusgard JL; Chumsri S; Bhandary L; Zhao XF; Lu S; Goloubeva OG; Polster BM; Fiskum GM; Girnun GD; Kim MS; Passaniti A
J Cell Biochem; 2015 Oct; 116(10):2210-26. PubMed ID: 25808624
[TBL] [Abstract][Full Text] [Related]
3. Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.
Liu K; Tang Z; Huang A; Chen P; Liu P; Yang J; Lu W; Liao J; Sun Y; Wen S; Hu Y; Huang P
Int J Oncol; 2017 Jan; 50(1):252-262. PubMed ID: 27878251
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
5. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
[TBL] [Abstract][Full Text] [Related]
7. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
9. SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.
Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
[TBL] [Abstract][Full Text] [Related]
10. Influence of the Twist gene on the invasion and metastasis of colon cancer.
Wang D; Rai B; Qi F; Liu T; Wang J; Wang X; Ma B
Oncol Rep; 2018 Jan; 39(1):31-44. PubMed ID: 29115546
[TBL] [Abstract][Full Text] [Related]
11. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
12. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
13. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells.
Wang H; Wang Y; Du Q; Lu P; Fan H; Lu J; Hu R
Exp Cell Res; 2016 Mar; 342(2):184-92. PubMed ID: 26968633
[TBL] [Abstract][Full Text] [Related]
15. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
[TBL] [Abstract][Full Text] [Related]
16. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
17. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
18. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
[TBL] [Abstract][Full Text] [Related]
19. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.
Mezencev R; Matyunina LV; Jabbari N; McDonald JF
BMC Cancer; 2016 Mar; 16():236. PubMed ID: 26988558
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]